Degroof Petercam Asset Management Charles River Laboratories International, Inc. Transaction History
Degroof Petercam Asset Management
- $8.32 Trillion
- Q1 2024
A detailed history of Degroof Petercam Asset Management transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Degroof Petercam Asset Management holds 1,200 shares of CRL stock, worth $223,392. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,200
Previous 1,200
-0.0%
Holding current value
$223,392
Previous $284 Million
14.62%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
695Shares Held
52.2MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.14 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$947 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$696 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$397 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$361 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.47B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...